Comparing two keyhole surgery methods for early lung cancer removal
Compares robotic and video-assisted keyhole surgery to remove early lung cancer.
Plain-language title generated from the registry record
Registry title: Lung cAncer Robotic Comparative Study
Key facts
- Where
- Copenhagen, DenmarkSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with early-stage non-small cell lung cancer who are scheduled for minimally invasive lung surgery, either robotic (da Vinci) or video-assisted (VATS).
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Clinical stage IA1-2 non-small cell lung cancer at the time of surgery.
Main reasons for not taking part
- Clinical stage IA3, II, III or IV lung cancer
- Lobectomy or segmentectomy as an emergency procedure
- Lobectomy or segmentectomy for metastatic cancer
- Bilobectomy or sleeve-lobectomy
- Pregnant or planning to become pregnant during the study
Read by machine on 9 November 2026.
Where in Denmark
- Copenhagen University Hospital, RigshospitaletCopenhagen, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Intuitive Surgical
- Trial code
- NCT06038227
- Record updated
- 14 September 2026
- Original description
To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.Read full original descriptionShow less
Comparing Outcomes for Minimally Invasive Techniques for Anatomic Lung Resection for Cancer - A Prospective, Comparative, Non-randomized, Open Label Post-market Observational Cohort Study Within Europe
To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.
Inclusion: Patient diagnosed with clinical stage IA1-2 non-small cell lung cancer at time of procedure; Patient scheduled to undergo minimally invasive surgery for NSCLC with either da Vinci robotic assisted surgery or VATs; Aged ≥ 18 years; Must be willing and able to comply with study requirements; Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form.
Exclusion: Patient receiving a lobectomy/segmentectomy as an emergency procedure; Patients receiving a lobectomy/segmentectomy for metastatic cancer; Patients with clinical stage IA3, II, III, and IV lung cancer; Patients scheduled to receive a bilobectomy or sleeve-lobectomy; Mental incapacity to understand or consent to study procedures; Anticipated difficulty for patient to comply with protocol requirements; Unable to comply with the follow up schedule; Pregnant or are planning to become pregnant during the study; Life expectancy < 12 months.